| Revenue growth | 26% YoY growth driven by volumes and Noida expansion. |
|---|---|
| Margins | Consolidated EBITDA margins steady at 23.8%; expansion-related costs offset gains. |
| Demand visibility | Strong visibility across Tier-2/3 cities; patient volumes up significantly. |
| Management confidence | Extremely confident, highlighting early Noida EBITDA break-even and volume demand. |
Growth
Growth is volume-led (IPD +28%, OPD +34%) with ARPOB increasing 5% from favorable case mix.
Outlook
Noida is expected to achieve EBITDA break-even ahead of previous schedules; capex is ~970 Crores for Guwahati.
Risks
EBITDA margins for established clusters face potential dilution from aggressive expansion and high-end doctor attrition.
Earnings Call Transcript filed with NSE, NSE: MEDANTA. Summary written with AI assistance from the document.
Global Health Ltd: key numbers
- Share price
- ₹1,286.70
- Market cap
- ₹34,596 Cr
- Revenue (annual)
- ₹4,410 Cr
- Net profit (annual)
- ₹556.5 Cr
- P/E (TTM)
- 62.2×Sector 53.1×
- Promoter holding
- 33.00%-0.01% QoQ
- FII holding
- 9.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Global Health Ltd
All →Global Health Employee Stock Options
Global Health Limited has allotted equity shares under its ESOP/ESPS scheme. This action results in a minor increase in the company's total paid-up share capital.
Global Health Employee Stock Options
Global Health Limited has allotted 3,000 equity shares under its employee stock option plan at a premium of Rs. 1,498 per share.
- Value
- ₹0.45 Cr
Global Health Annual General Meeting
Global Health Limited held its 22nd Annual General Meeting on September 16, 2026. The meeting covered financial statement adoption and shareholder dividend declaration.
Global Health Other Announcement
Global Health Limited has filed its Business Responsibility and Sustainability Report for the financial year 2025-26 as mandated by SEBI (LODR) regulations.
Global Health Annual General Meeting
Global Health Limited has announced its 22nd Annual General Meeting to be held on September 16, 2026, to consider financial statements, dividends, and director re-appointment.
- Value
- ₹0.12 Cr
Global Health Annual Report
Global Health Limited has submitted its Annual Report for the financial year 2025-26, alongside the notice for its 22nd Annual General Meeting.